Market Cap 3.02B
Revenue (ttm) 588.99M
Net Income (ttm) 214.33M
EPS (ttm) N/A
PE Ratio 9.81
Forward PE 9.01
Profit Margin 36.39%
Debt to Equity Ratio 0.00
Volume 616,200
Avg Vol 1,203,160
Day's Range N/A - N/A
Shares Out 122.12M
Stochastic %K 80%
Beta 0.67
Analysts Strong Sell
Price Target $33.75

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 420 3200
Address:
355 Alhambra Circle, Suite 801, Coral Gables, United States
DeMontoire
DeMontoire Apr. 1 at 9:49 PM
$CPRX it is my third around it!
1 · Reply
111ggg
111ggg Apr. 1 at 7:02 PM
$CPRX Hit that 25 barrier again. You could make a living just by buying 1000 shrs at 23 and selling at 25 over and over again.
1 · Reply
donkeykongreturns
donkeykongreturns Mar. 31 at 3:14 PM
$CPRX Must just be lucky or something
0 · Reply
111ggg
111ggg Mar. 31 at 2:32 PM
$CPRX just cannot get over that 25 hump. Maybe after lawsuit goes in their favor.
0 · Reply
Doozio
Doozio Mar. 31 at 2:00 PM
$CPRX 🐒🍌🧠⏰♾️
0 · Reply
StillWaiting101
StillWaiting101 Mar. 30 at 6:58 PM
$CPRX not to mention even XBI is down 3% YTD, so its not like we are getting propped up by our sector. People talk about "opportunity cost" but always fail to realize that cuts both ways, the only opportunity we are missing right now would be the opportunity to be losing money if you parked money somewhere else.
0 · Reply
StillWaiting101
StillWaiting101 Mar. 30 at 6:53 PM
$CPRX SPY is down almost 8% year to date, there is a laundry list to large caps down 20-40% YTD, such as MSFT, UNH, GIS, RDDT, TTD, APP, the list goes on and on, yet here we are holding steady up 2% YTD, we may be a slow burn, but it can't be understated how important strong financials are in times like these. We may not get the huge moves up and have the hype or be flashy enough for some investors, but you never have to worry about losing money here as long as you are patient. Hype fades when the market is struggling, but a mountain of cash and not racking up debt is always going to keep us steady while we wait.
2 · Reply
ElissaL
ElissaL Mar. 30 at 2:04 PM
$CPRX As to the Hetero litigation, I have the following thoughts: 1. As to the potential expiration of the 30-month stay, if the stay does expire while the litigation is ongoing, Hetero has two choices. It can either act as if the stay is still in effect and not start selling generic Firdapse after it receives FDA approval until the litigation concludes, or it can start selling generic Firdapse after it receives FDA approval. Starting to sell comes at a significant risk to Hetero because if the judge finds after the trial that patent infringement occurred, then Hetero may owe massive damages to Catalyst, which could be a large percentage of the profits Hetero made from Firdapse sales. Alternatively, Catalyst can file a motion to extend the stay or the judge can extend the stay on his own. Catalyst firmly believes in its patents and has an experienced patent litigation attorney team, so I have to believe Catalyst would file this motion if the judge does not act first. See #2 in my reply.
4 · Reply
BlackSwan13
BlackSwan13 Mar. 27 at 6:26 PM
$CPRX Rebecca Fatbags
0 · Reply
toradio
toradio Mar. 27 at 2:24 PM
$CPRX almost an hour into the trading day.... and the volume is less than 70k... must be friday....jmho
0 · Reply
Latest News on CPRX
Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:08 AM EDT - 10 months ago

Strong Inflows Make Catalyst Stock an Outlier


Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 26, 2025, 8:12 AM EDT - 1 year ago

Strong Revenue, Drug Performance Lift Catalyst Shares


Catalyst Remains a Big Money Favorite

Feb 7, 2025, 3:56 PM EST - 1 year ago

Catalyst Remains a Big Money Favorite


DeMontoire
DeMontoire Apr. 1 at 9:49 PM
$CPRX it is my third around it!
1 · Reply
111ggg
111ggg Apr. 1 at 7:02 PM
$CPRX Hit that 25 barrier again. You could make a living just by buying 1000 shrs at 23 and selling at 25 over and over again.
1 · Reply
donkeykongreturns
donkeykongreturns Mar. 31 at 3:14 PM
$CPRX Must just be lucky or something
0 · Reply
111ggg
111ggg Mar. 31 at 2:32 PM
$CPRX just cannot get over that 25 hump. Maybe after lawsuit goes in their favor.
0 · Reply
Doozio
Doozio Mar. 31 at 2:00 PM
$CPRX 🐒🍌🧠⏰♾️
0 · Reply
StillWaiting101
StillWaiting101 Mar. 30 at 6:58 PM
$CPRX not to mention even XBI is down 3% YTD, so its not like we are getting propped up by our sector. People talk about "opportunity cost" but always fail to realize that cuts both ways, the only opportunity we are missing right now would be the opportunity to be losing money if you parked money somewhere else.
0 · Reply
StillWaiting101
StillWaiting101 Mar. 30 at 6:53 PM
$CPRX SPY is down almost 8% year to date, there is a laundry list to large caps down 20-40% YTD, such as MSFT, UNH, GIS, RDDT, TTD, APP, the list goes on and on, yet here we are holding steady up 2% YTD, we may be a slow burn, but it can't be understated how important strong financials are in times like these. We may not get the huge moves up and have the hype or be flashy enough for some investors, but you never have to worry about losing money here as long as you are patient. Hype fades when the market is struggling, but a mountain of cash and not racking up debt is always going to keep us steady while we wait.
2 · Reply
ElissaL
ElissaL Mar. 30 at 2:04 PM
$CPRX As to the Hetero litigation, I have the following thoughts: 1. As to the potential expiration of the 30-month stay, if the stay does expire while the litigation is ongoing, Hetero has two choices. It can either act as if the stay is still in effect and not start selling generic Firdapse after it receives FDA approval until the litigation concludes, or it can start selling generic Firdapse after it receives FDA approval. Starting to sell comes at a significant risk to Hetero because if the judge finds after the trial that patent infringement occurred, then Hetero may owe massive damages to Catalyst, which could be a large percentage of the profits Hetero made from Firdapse sales. Alternatively, Catalyst can file a motion to extend the stay or the judge can extend the stay on his own. Catalyst firmly believes in its patents and has an experienced patent litigation attorney team, so I have to believe Catalyst would file this motion if the judge does not act first. See #2 in my reply.
4 · Reply
BlackSwan13
BlackSwan13 Mar. 27 at 6:26 PM
$CPRX Rebecca Fatbags
0 · Reply
toradio
toradio Mar. 27 at 2:24 PM
$CPRX almost an hour into the trading day.... and the volume is less than 70k... must be friday....jmho
0 · Reply
BlackSwan13
BlackSwan13 Mar. 27 at 1:51 PM
$CPRX 10 bagger
0 · Reply
StillWaiting101
StillWaiting101 Mar. 26 at 6:45 PM
$CPRX look at it just chugging away while everything else goes scorched earth, its beautiful
1 · Reply
StillWaiting101
StillWaiting101 Mar. 25 at 7:29 PM
$CPRX ol reliable, don't even have to worry about this
1 · Reply
111ggg
111ggg Mar. 24 at 5:18 PM
$CPRX For about the sixth time overvtge past year, this stock has turned into garbage territory. Of course, aboht every stock in this sector is in same boat.
0 · Reply
JackDarwin
JackDarwin Mar. 21 at 8:38 AM
$CPRX Bullish Tweezer Candlestick Pattern Formed at Downtrend with Jump in Volume
0 · Reply
StillWaiting101
StillWaiting101 Mar. 20 at 7:39 PM
$CPRX relative strength here, just don't look outside, its getting rough everywhere else
0 · Reply
111ggg
111ggg Mar. 20 at 1:35 PM
$CPRX what sucker paid up to buy premarket. Never buy premarket
0 · Reply
BlackSwan13
BlackSwan13 Mar. 19 at 3:00 PM
$CPRX tis stock has already managed 1 world war. can it manage another?
0 · Reply
Calinda
Calinda Mar. 18 at 6:48 PM
$CPRX reposting as a stand-alone, not just a reply, to increase visibility: Update “Trial will go forward on May 18 and 19, and if necessary on the morning of May 20. And trial will go forward on May 26 and if necessary on the morning of May 27. So ordered...” These were the dates offered in the 3/6 letter from CPRX’s legal firm indicating the dates were collectively reached with defendants to establish availability of experts who could/should then testify together. IMO Hetero et al has run out of attempted trial interference / manipulation to muddy the waters with failing expertise.
0 · Reply
Sowa5000
Sowa5000 Mar. 18 at 12:44 PM
$CPRX Anybody got anything on the court case wondering if you think they settle before Friday. I know they have already settled with 2 of the 3. Need a quick settlement or could get ugly.
2 · Reply
zyx123
zyx123 Mar. 16 at 8:21 PM
$CPRX what's with that candle at close? Maybe good news regarding trial?
1 · Reply
Starrider111
Starrider111 Mar. 13 at 2:32 PM
I bought $CPRX & $WY today
0 · Reply